Last Updated: May 27, 2023 @ 9:13 am | ||
2770 | Herpes Simplex Virus, DNA | |
Specimen: | Collect: |
|
Submit: |
| |
Special Handling: |
| |
Rejection Criteria: |
| |
Stability: | Ambient: Unacceptable; Refrigerated: 7 Day(s); Frozen: Unacceptable; Incubated: Unacceptable | |
Methodology: |
| |
Performed: | Sun-Sat | |
Reported: | 1-3 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | Please see report for interpretive data. This assay was performed by illumigene, which detects the target regions of the HSV 1 and 2 genomes by DNA amplification. Performance has been established with male and female cutaneous and mucocutaneous lesion specimens only. It is a qualitative assay and does not distinguish between viable and nonviable organisms. Negative results do not preclude infection and should not be used as the sole basis for treatment or other patient management decisions. Results of some tests may be reported as invalid due to substances in the specimen that are inhibitory to PCR amplification, such as Zincum Gluconicum (7%) and Casein (>5 mg/mL). | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.